These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Impact of the SARS-CoV-2 epidemic on private ENT consulting practice during the first month of lockdown in Réunion Island in 2020. Rubin F; Vellin JF; Berkaoui J; Al Assaf W; Pennica A; Girard B; Hoarau P; Pescatori P; Dupre M; Bensoussan S; Vurpillot P; Challut N; Laccourreye O Eur Ann Otorhinolaryngol Head Neck Dis; 2020 Sep; 137(4):251-256. PubMed ID: 32712116 [TBL] [Abstract][Full Text] [Related]
46. [Acro-ischemic injuries in children-adolescents during CoViD-19 pandemic: from lifestyle changes due to lockdown to interferone.]. Marchetti F; Guiducci C; Bigucci B; Iacono A; Calderoni O; Sorci MR; Sparacino M; Semprini S; Vergine G Recenti Prog Med; 2020 Sep; 111(9):480-486. PubMed ID: 32914775 [TBL] [Abstract][Full Text] [Related]
47. Hand injuries treated at a hand emergency center during the COVID-19 lockdown. Régas I; Bellemère P; Lamon B; Bouju Y; Lecoq FA; Chaves C Hand Surg Rehabil; 2020 Oct; 39(5):459-461. PubMed ID: 32777488 [TBL] [Abstract][Full Text] [Related]
48. Global quieting of high-frequency seismic noise due to COVID-19 pandemic lockdown measures. Lecocq T; Hicks SP; Van Noten K; van Wijk K; Koelemeijer P; De Plaen RSM; Massin F; Hillers G; Anthony RE; Apoloner MT; Arroyo-Solórzano M; Assink JD; Büyükakpınar P; Cannata A; Cannavo F; Carrasco S; Caudron C; Chaves EJ; Cornwell DG; Craig D; den Ouden OFC; Diaz J; Donner S; Evangelidis CP; Evers L; Fauville B; Fernandez GA; Giannopoulos D; Gibbons SJ; Girona T; Grecu B; Grunberg M; Hetényi G; Horleston A; Inza A; Irving JCE; Jamalreyhani M; Kafka A; Koymans MR; Labedz CR; Larose E; Lindsey NJ; McKinnon M; Megies T; Miller MS; Minarik W; Moresi L; Márquez-Ramírez VH; Möllhoff M; Nesbitt IM; Niyogi S; Ojeda J; Oth A; Proud S; Pulli J; Retailleau L; Rintamäki AE; Satriano C; Savage MK; Shani-Kadmiel S; Sleeman R; Sokos E; Stammler K; Stott AE; Subedi S; Sørensen MB; Taira T; Tapia M; Turhan F; van der Pluijm B; Vanstone M; Vergne J; Vuorinen TAT; Warren T; Wassermann J; Xiao H Science; 2020 Sep; 369(6509):1338-1343. PubMed ID: 32703907 [TBL] [Abstract][Full Text] [Related]
49. Climate, demographic factors and geographical variations in the incidence of invasive meningococcal disease in Italy. Vescio F; Busani L; Mughini Gras L; Fazio C; Neri A; Avellis L; Rezza G; Stefanelli P Epidemiol Infect; 2015 Jun; 143(8):1742-50. PubMed ID: 25308801 [TBL] [Abstract][Full Text] [Related]
51. Population-based study of influenza and invasive meningococcal disease among Greek children during the COVID-19 pandemic. Ktena D; Kourkouni E; Kontopidou F; Gkolfinopoulou K; Papadima K; Georgakopoulou T; Magaziotou I; Andreopoulou A; Tzanakaki G; Zaoutis T; Papaevangelou V BMJ Paediatr Open; 2022 Mar; 6(1):. PubMed ID: 36053653 [TBL] [Abstract][Full Text] [Related]
52. Changes in Invasive Deghmane AE; Taha MK Microorganisms; 2022 Apr; 10(5):. PubMed ID: 35630352 [TBL] [Abstract][Full Text] [Related]
53. Impact of the COVID-19 pandemic on clinical research in hospitals: observational study in the first epicenter of the epidemic during the general lockdown in France. Becker G; Martin T; Sabo AN; Bertrand F; Hutt A; Ayme-Dietrich E; Michel B; Monassier L; Gourieux B Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):1158-1162. PubMed ID: 33577072 [TBL] [Abstract][Full Text] [Related]
54. Risk factors for meningococcal disease in children and adolescents: a systematic review and META-analysis. Spyromitrou-Xioufi P; Tsirigotaki M; Ladomenou F Eur J Pediatr; 2020 Jul; 179(7):1017-1027. PubMed ID: 32405695 [TBL] [Abstract][Full Text] [Related]
55. Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database. Taha MK; Weil-Olivier C; Bouée S; Emery C; Nachbaur G; Pribil C; Loncle-Provot V Hum Vaccin Immunother; 2021 Jun; 17(6):1858-1866. PubMed ID: 33449835 [TBL] [Abstract][Full Text] [Related]
56. A database study of clinical and economic burden of invasive meningococcal disease in France. Huang L; Fievez S; Goguillot M; Marié L; Bénard S; Elkaïm A; Tin Tin Htar M PLoS One; 2022; 17(4):e0267786. PubMed ID: 35486581 [TBL] [Abstract][Full Text] [Related]
57. Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database. Weil-Olivier C; Taha MK; Bouée S; Emery C; Loncle-Provot V; Nachbaur G; Beck E; Pribil C Hum Vaccin Immunother; 2022 Dec; 18(1):2021764. PubMed ID: 35192785 [TBL] [Abstract][Full Text] [Related]
58. Meningococcal Disease in the Post-COVID-19 Era: A Time to Prepare. Bloom DE; Bonanni P; Martinón-Torres F; Richmond PC; Safadi MAP; Salisbury DM; Charos A; Schley K; Findlow J; Balmer P Infect Dis Ther; 2023 Dec; 12(12):2649-2663. PubMed ID: 38048020 [TBL] [Abstract][Full Text] [Related]
59. Inference of transmission dynamics and retrospective forecast of invasive meningococcal disease. Cascante-Vega J; Galanti M; Schley K; Pei S; Shaman J PLoS Comput Biol; 2023 Oct; 19(10):e1011564. PubMed ID: 37889910 [TBL] [Abstract][Full Text] [Related]
60. Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM). Shen J; Bouée S; Aris E; Emery C; Beck EC Infect Dis Ther; 2022 Feb; 11(1):249-262. PubMed ID: 34791633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]